RG-13291

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameRG-13291
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein-tyrosine kinases inhibitors
TargetsProtein-tyrosine kinases
Therapy Area/IndicationsAtherosclerosisCoronary Restenosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAventis
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAventis
Active IndicationsN/A
Inactive IndicationsAtherosclerosisCoronary Restenosis

Other Information

ATC CodeN/A
Related LinksN/A